Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$190.90 USD
+0.18 (0.09%)
Updated Oct 13, 2025 03:59 PM ET
After-Market: $190.73 -0.17 (-0.09%) 6:24 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/14/2025
Time: BMO |
9/2025 | $2.77 | 2.17% |
Earnings Summary
For their last quarter, Johnson & Johnson (JNJ) reported earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This reflects a positive earnings surprise of 4.14%. Look out for JNJ's next earnings release on October 14, 2025. For the next earning release, we expect the company to report earnings of $2.77 per share, reflecting a year-over-year increase of 14.46%.
Earnings History
Price & Consensus
Zacks News for JNJ
Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is J&J's MedTech Segment Set for Another Quarter of Growth?
3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR
Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
JNJ FAQs
Johnson & Johnson (JNJ) has announced they will report their next quarter earnings on October 14, 2025. For the next earning release, we expect the company to report earnings of $2.77 per share, reflecting a year-over-year increase of 14.46%.
Johnson & Johnson has announced they will report their previous quarter earnings after the close of the market on October 14, 2025.
The Zacks Consensus Estimate for Johnson & Johnson (JNJ) for the quarter ending in September 2025 is $2.77 a share. We expect Johnson & Johnson to miss by 2.17%.
In the earnings report for the quarter ending in September 2024, Johnson & Johnson (JNJ) announced earnings of $2.42 per share versus the Zacks Consensus Estimate of $2.22 per share, representing a surprise of 9.01%.